ライフサイエンスコーパス: levels were measured

1 binding protein, troponin T, and brain natriuretic peptide levels were measured.

2 Subjective mood, satiety, and circulating hormone levels were measured.

3 type 1 and brain-derived neurotrophic factor (BDNF) protein levels were measured.

4 th cholangiocyte supernatants and alpha-smooth muscle actin levels were measured.

5 Additionally, fecal pH and microbial metabolite levels were measured.

6 e DNA (cfDNA), and plasma citrullinated histone H3 (Cit H3) levels were measured.

7 ted with variants of PPARGC1A and protein and messenger RNA levels were measured.

8 sting serum lipids and serum alanine aminotransferase (ALT) levels were measured and an abdominal ultrasound was performe

9 Serum cytokine and chemokine levels were measured at baseline and after BV.

10 codynamic substudy from 4 phase 2 trials, circulating PCSK9 levels were measured at baseline and then weekly at weeks 8 t

11 andem mass spectrometry assay; follicle-stimulating hormone levels were measured at baseline and week 4.

12 Circulating PCSK9 levels were measured at baseline using quantitative enzyme-li

13 The highest C1-INHc+f , C4, and C1(q,r,s) levels were measured at baseline, and their continuous decrea

14 Serum cytokine levels were measured at baseline.

15 Hs-cTnI levels were measured at presentation and after 1 hour in a bl

16 Plasma adipokine levels were measured at three time points (pre-infusion basel

17 Serum cytokine and tryptase levels were measured before and after a positive oral food ch

18 in hepatic steatosis at 48 weeks of follow-up over baseline levels were measured by CAP.

19 Circulating BMP-9 levels were measured by ELISA.

20 Serum levels were measured by ELISA.

21 Histamine and leptin levels were measured by enzyme immunoassay.

22 Cord blood mononuclear cell-derived IL-1beta levels were measured by means of ELISA.

23 Liver was analyzed by immunohistochemistry and mRNA levels were measured by quantitative reverse transcription po

24 Plasma miRNA levels were measured by reverse-transcription quantitative po

25 Serum total and allergen-specific IgE (sIgE) levels were measured by using ImmunoCAP.

26 Gadolinium levels were measured by using inductively coupled plasma mass

27 Total IgE levels were measured by using the UniCAP 100 system.

28 Glucagon levels were measured during OGTT in a total of 4,194 individu

29 In addition, serum activin levels were measured from a retrospective clinical cohort of

30 Circulating CXCL5 levels were measured from plasma, and both DNA genotyping and

31 TSLP) and transforming growth factor beta (TGF-beta) plasma levels were measured in 22 pediatric patients with active dis

32 pecific IgE levels, blood eosionophil counts, and periostin levels were measured in 244 children.

33 PB-MRD levels were measured in 393, 337, and 474 patients from CLL8,

34 2 and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were measured in a central laboratory.

35 Claudin-18.1 mRNA levels were measured in airway epithelial brushings from heal

36 (C1-INHc+f ), C1(q,r,s), C3, C4, C3a, C4a, C5a, and SC5b-9 levels were measured in blood samples obtained during the 96-

37 sNfL levels were measured in healthy controls (HC, n = 254) and tw

38 Within a population-based birth cohort, eNO levels were measured in healthy term infants aged 5 weeks dur

39 Serum chymase levels were measured in patients presenting with undifferenti

40 Thus, FGF23 and soluble KL levels were measured in plasma from 48 CF patients and in pri

41 Menin and miR-24 expression levels were measured in the following intrahepatic and extrah

42 Cytokine levels were measured in the PASTURE cohort.

43 in IL33 and soluble suppression of tumorigenicity 2 (sST2) levels were measured in the plasma and correlated with levels

44 Although neither craving nor CP-AMPAR levels were measured in the present study, we killed rats at

45 ating hormone (FSH) and sex hormone-binding globulin (SHBG) levels were measured in the three matrices.

46 Tumor HA levels were measured retrospectively using a novel affinity h

47 The metabolite levels were measured using LC-MS following treatment with col

48 Endocannabinoid levels were measured using liquid chromatography-mass spectro

49 p-STAT3 levels were measured using Western blot.

50 HEV antigen levels were measured with the Wantai enzyme-linked immunosorb